21-Apr-2026
No press releases found.
Eli Lilly nears $2B-plus deal for Kelonia to expand cancer pipeline: WSJ
Seeking Alpha News (Sun, 19-Apr 6:08 PM ET)
The Fund seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015.
Direxion Daily S&P Biotech Bull 3X ETF trades on the ARCA stock market under the symbol LABU.
As of April 21, 2026, LABU stock price declined to $200.27 with 436,753 million shares trading.
LABU has a beta of 2.61, meaning it tends to be more sensitive to market movements. LABU has a correlation of 0.27 to the broad based SPY ETF.
LABU has a market cap of $495.57 million. This is considered a Small Cap stock.
In the last 3 years, LABU traded as high as $212.45 and as low as $32.55.
LABU has outperformed the market in the last year with a price return of +337.1% while the SPY ETF gained +38.4%. LABU has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +10.4% and +17.5%, respectively, while the SPY returned +3.0% and +6.8%, respectively.
LABU support price is $194.25 and resistance is $218.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LABU shares will trade within this expected range on the day.
